These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 2642107

  • 1. Safe conversion from cyclosporine to azathioprine with improved renal function in pediatric renal transplantation.
    Kaiser BA, Lawless ST, Palmer JM, Dunn SP, Polinsky MS, Baluarte HJ.
    Pediatr Nephrol; 1989 Oct; 3(4):401-5. PubMed ID: 2642107
    [Abstract] [Full Text] [Related]

  • 2. Elective conversion from cyclosporine to azathioprine in recipients with stable renal function 6 months after kidney transplantation.
    Thistlethwaite JR, Haag BW, Jones KW, Stuart JK, Stuart FP.
    Hum Immunol; 1985 Nov; 14(3):314-23. PubMed ID: 3902749
    [Abstract] [Full Text] [Related]

  • 3. Treatment of chronic renal allograft rejection with cyclosporine and prednisone.
    Rosenblum ND, Harmon WE, Levey RH.
    Transplantation; 1988 Jan; 45(1):232-4. PubMed ID: 3276052
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Immunosuppressive conversion from cyclosporine A to azathioprine in renal transplant patients.
    Paraiso AR, Ona ET, Alano FA, Ramos CP, De Luna M.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1627. PubMed ID: 2652530
    [No Abstract] [Full Text] [Related]

  • 6. Cyclosporine toxicity: the effect of combined therapy using cyclosporine, azathioprine, and prednisone.
    Lorber MI, Flechner SM, Van Buren CT, Sorensen K, Kerman RH, Kahan BD.
    Am J Kidney Dis; 1987 Jun; 9(6):476-84. PubMed ID: 3296744
    [Abstract] [Full Text] [Related]

  • 7. The utility of cyclosporine weaning in renal transplantation.
    Loertscher R, Blier L, Steinmetz O, Nohr C.
    Ann Surg; 1992 Apr; 215(4):368-76. PubMed ID: 1558418
    [Abstract] [Full Text] [Related]

  • 8. Long-term beneficial effects of azathioprine addition to ongoing cyclosporine-prednisone protocol in renal transplantation.
    Pascual J, Marcén R, Orofino L, Quereda C, Teruel JL, Mampaso F, Liaño F, Villafruela JJ, Ortuño J.
    Transpl Int; 1992 Apr; 5 Suppl 1():S107-9. PubMed ID: 14621748
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. T-lymphocyte subsets in renal allograft recipients treated with cyclosporine and azathioprine.
    Sumpio BE, Dwyer JM, Flye MW.
    Ann Surg; 1987 Jan; 205(1):49-53. PubMed ID: 3541801
    [Abstract] [Full Text] [Related]

  • 11. Selective conversion from azathioprine to cyclosporin for steroid-resistant rejection in renal transplants: an alternative therapy.
    Crowson MC, Berisa F, McGonigle RJ, Adu D, Michael J, Barnes AD.
    Nephrol Dial Transplant; 1989 Jan; 4(2):129-32. PubMed ID: 2496354
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Amelioration of chronic renal allograft dysfunction in cyclosporine-treated patients by addition of azathioprine.
    Rocher LL, Hodgson RJ, Merion RM, Swartz RD, Keavey S, Turcotte JG, Campbell DA.
    Transplantation; 1989 Feb; 47(2):249-54. PubMed ID: 2645707
    [Abstract] [Full Text] [Related]

  • 14. Beneficial effects of cyclosporine compared with azathioprine in cadaveric renal transplantation.
    Henry ML, Sommer BG, Ferguson RM.
    Am J Surg; 1985 Nov; 150(5):533-6. PubMed ID: 2998215
    [Abstract] [Full Text] [Related]

  • 15. Results of conversion from cyclosporine to azathioprine in cadaveric renal transplantation.
    Gonwa TA, Nghiem DD, Schulak JA, Corry RJ.
    Transplantation; 1987 Feb; 43(2):225-8. PubMed ID: 3544380
    [Abstract] [Full Text] [Related]

  • 16. Use of cyclosporine in pediatric renal transplant recipients.
    Conley SB, Flechner SM, Rose G, Van Buren CT, Brewer E, Kahan BD.
    J Pediatr; 1985 Jan; 106(1):45-9. PubMed ID: 3880820
    [Abstract] [Full Text] [Related]

  • 17. The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients.
    Boudreaux JP, McHugh L, Canafax DM, Ascher N, Sutherland DE, Payne W, Simmons RL, Najarian JS, Fryd DS.
    Transplantation; 1987 Sep; 44(3):376-81. PubMed ID: 3307061
    [Abstract] [Full Text] [Related]

  • 18. Risk of acute cellular rejection after azathioprine withdrawal in stable renal allograft recipients on cyclosporine, azathioprine, and prednisone.
    Fabrega AJ, Roy G, Reynolds L, Corwin C, Hunsicker L.
    Transplant Proc; 1998 Jun; 30(4):1335-6. PubMed ID: 9636543
    [No Abstract] [Full Text] [Related]

  • 19. Conversion from cyclosporine to azathioprine in renal allograft recipients.
    Rocher LL, Milford EL, Kirkman RL, Carpenter CB, Strom TB, Tilney NL.
    Transplantation; 1984 Dec; 38(6):669-74. PubMed ID: 6390830
    [Abstract] [Full Text] [Related]

  • 20. Results of the Minnesota randomized prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
    Sutherland DE, Fryd DS, Strand MH, Canafax DM, Ascher NL, Payne WD, Simmons RL, Najarian JS.
    Am J Kidney Dis; 1985 Jun; 5(6):318-27. PubMed ID: 3893106
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.